Silver Oak Securities’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$617K Sell
1,596
-134
-8% -$49.7K 0.04% 409
2026
Q1
$506K Buy
1,730
+72
+4% +$23.7K 0.04% 435
2025
Q4
$578K Buy
1,658
+8
+0.5% +$2.7K 0.04% 420
2025
Q3
$533K Buy
1,650
+85
+5% +$26.4K 0.04% 410
2025
Q2
$609K Buy
1,565
+262
+20% +$105K 0.05% 360
2025
Q1
$563K Sell
1,303
-505
-28% -$203K 0.05% 348
2024
Q4
$667K Sell
1,808
-153
-8% -$64K 0.06% 316
2024
Q3
$1.02M Buy
1,961
+1,741
+791% +$930K 0.11% 196
2024
Q2
$119K Buy
220
+15
+7% +$7.93K 0.02% 421
2024
Q1
$106K Sell
205
-1,269
-86% -$631K 0.02% 423
2023
Q4
$695K Buy
1,474
+1,272
+630% +$588K 0.09% 226
2023
Q3
$88K Buy
+202
New +$91.6K 0.02% 345
2022
Q4
Sell
-202
Closed -$88K 355
2022
Q3
$88K Buy
+202
New +$96.7K 0.02% 345

Other funds holding ELV

Silver Oak Securities's ELV Position: Q2 2026 in Review

Silver Oak Securities reduced its Elevance Health (ELV) stake by 7.7% in Q2 2026, selling an estimated $49.7K and leaving 1,596 shares worth $617K. The position accounts for 0.04% of the portfolio, ranked #409.

Silver Oak Securities first reported a position in ELV in Q3 2022 and has held it in 13 quarters since. The position peaked at $1.02M in Q3 2024. 1,601 funds tracked by Wall St. Rank hold ELV as of Q2 2026.

  • Silver Oak Securities held 1,596 shares of Elevance Health worth $617K as of Q2 2026.
  • Silver Oak Securities sold 134 Elevance Health shares in Q2 2026, an estimated $49.7K.
  • Elevance Health made up 0.04% of Silver Oak Securities's portfolio in Q2 2026, its #409 holding.
  • Silver Oak Securities first reported a position in Elevance Health in Q3 2022 and has held it in 13 quarters since.
  • Silver Oak Securities's Elevance Health position peaked at $1.02M in Q3 2024.
  • 1,601 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.

Based on Silver Oak Securities's 13F filing for Q2 2026, filed 7 Aug 2026.